MedVellum
MedVellum
Back to Library
General Surgery
Gastroenterology
Emergency Medicine
EMERGENCY

Acute Cholecystitis

High EvidenceUpdated: 2025-12-24

On This Page

Red Flags

  • Gangrenous cholecystitis
  • Perforation with biliary peritonitis
  • Sepsis/septic shock
  • Emphysematous cholecystitis (gas-forming organisms)
  • Mirizzi syndrome (compression of hepatic duct)
  • Gallbladder empyema
Overview

Acute Cholecystitis

1. Clinical Overview

Summary

Acute cholecystitis is inflammation of the gallbladder, most commonly caused by gallstone impaction in the cystic duct (calculous cholecystitis; ~90% of cases). Obstruction leads to gallbladder distension, mucosal ischaemia, bacterial infection, and progressive inflammation. The classic presentation is Murphy's sign positive with right upper quadrant pain, fever, and leukocytosis. Ultrasound is the imaging modality of choice, showing gallstones, wall thickening, and pericholecystic fluid. The Tokyo Guidelines (TG18) provide standardised diagnostic criteria and severity grading. Current evidence strongly supports early laparoscopic cholecystectomy (ideally within 72 hours if haemodynamically stable) as first-line treatment. For high-risk patients unfit for surgery, percutaneous cholecystostomy provides source control until definitive surgery can be performed.

Key Facts

  • Aetiology: 90% calculous (gallstones); 10% acalculous (critically ill, TPN, burns)
  • Murphy's sign: Inspiratory arrest on RUQ palpation — 65% sensitive, 87% specific
  • Ultrasound findings: Gallstones, wall thickening >3mm, pericholecystic fluid, sonographic Murphy's
  • Tokyo criteria: Definite diagnosis = Local signs + Systemic signs + Imaging findings
  • Treatment: Early laparoscopic cholecystectomy (within 72 hours is optimal)
  • Mortality: <1% for uncomplicated; up to 10% for gangrenous/perforated
  • Complications: Gangrene (15-20%), perforation, empyema, cholangitis
  • Acalculous cholecystitis: 5-10% of cases; ICU patients; high mortality

Clinical Pearls

"Early Surgery Saves Lives": Landmark trials (ACDC, CHOCOLA) show early cholecystectomy (<72h) is superior to delayed surgery. Don't wait — operate when fit, preferably on index admission.

"Murphy's Sign = Positive Predictive Gold": A positive Murphy's sign (inspiration arrested by examiner's hand pressing on RUQ) has high specificity. If positive with stones on ultrasound, diagnosis is almost certain.

"The Tokyo Criteria Systematise Diagnosis": TG18 requires local signs (Murphy's, RUQ mass) + systemic signs (fever, raised WCC/CRP) + imaging evidence (US findings) for definite diagnosis.

"Acalculous = ICU Death Trap": Acalculous cholecystitis occurs in critically ill patients (sepsis, burns, TPN, post-op). It has high mortality (up to 50%) due to delayed diagnosis. Maintain high index of suspicion.

"Cholecystostomy Is a Bridge": Percutaneous cholecystostomy is a life-saving temporising measure in the unfit patient. It provides source control — definitive surgery (interval cholecystectomy) follows once patient is optimised.

Why This Matters Clinically

Acute cholecystitis is one of the most common surgical emergencies. Prompt recognition and treatment prevent life-threatening complications (gangrene, perforation, sepsis). The shift towards early surgery has improved outcomes significantly. Every clinician should be able to recognise the clinical features, interpret ultrasound findings, initiate appropriate management, and refer urgently for surgical assessment.[1,2]


2. Epidemiology

Incidence & Prevalence

ParameterData
Gallstone prevalence10-15% of adults have gallstones
Lifetime cholecystitis risk1-4% of patients with gallstones develop cholecystitis/year
Cholecystectomy volume~70,000 per year in UK
Peak age50-70 years
Sex ratioF:M = 3:1 (for gallstones); less disparity for cholecystitis

Risk Factors

FactorNotes
GallstonesPresent in 90% (calculous cholecystitis)
Female sexHigher gallstone prevalence
AgeIncreasing age
ObesityIncreased cholesterol stones
Rapid weight lossPredisposes to stone formation
Pregnancy / MultiparityHormonal effects on bile composition
Diabetes mellitusIncreased risk of complicated cholecystitis
Critical illnessAcalculous cholecystitis risk
TPNBile stasis
ImmunosuppressionAtypical presentations, increased complications

3. Pathophysiology

Mechanism (Calculous)

Step 1: Cystic Duct Obstruction

  • Gallstone impacts in cystic duct
  • Gallbladder distension with bile
  • Increased intraluminal pressure

Step 2: Mucosal Injury

  • Bile salts cause direct mucosal damage
  • Prostaglandin release → Inflammation
  • Phospholipase A activation → Lysolecithin (toxic to mucosa)

Step 3: Bacterial Infection

  • Secondary bacterial colonisation (ascending from duodenum)
  • Common organisms: E. coli, Klebsiella, Enterococcus
  • Suppurative inflammation

Step 4: Progressive Inflammation

  • Gallbladder wall oedema and thickening
  • Vascular compromise → Ischaemia → Gangrene (15-20%)
  • Perforation if untreated (~10% of gangrenous cases)

Acalculous Cholecystitis

FeatureDetails
DefinitionCholecystitis without gallstones
SettingCritical illness, ICU, post-major surgery, burns, sepsis, TPN
MechanismBile stasis + ischaemia + impaired gallbladder motility
MortalityVery high (up to 50%) due to delayed diagnosis and underlying disease
DiagnosisHigh index of suspicion; US may show sludge, wall thickening

Complications Pathway

ComplicationRiskFeatures
Gangrenous cholecystitis15-20%Necrotic wall; may perforate
Perforation3-10% (of gangrenous)Localised abscess or free perforation
EmpyemaVariablePus-filled gallbladder
Cholecystoenteric fistulaRareGallstone ileus if stone passes
Mirizzi syndromeRareStone in cystic duct compressing CHD

4. Clinical Presentation

Symptoms

SymptomFrequencyNotes
RUQ pain95%Constant, severe, radiating to scapula
Fever50-70%May be absent in elderly/immunosuppressed
Nausea/vomiting60-70%Common
AnorexiaCommonNon-specific
Previous biliary colic50%Prior episodes of RUQ pain post-fatty meal

Signs

SignSensitivitySpecificityNotes
Murphy's sign65%87%Inspiratory arrest on RUQ palpation
RUQ tenderness95%VariableMay have guarding
Fever >38°C50%VariableMay be absent
Palpable gallbladder<10%HighSuggests empyema/distension
Jaundice15-20%—Suggests CBD stone or Mirizzi syndrome

Red Flags

[!CAUTION] Red Flags — Severe/Complicated Cholecystitis:

  • Sepsis or septic shock (hypotension, tachycardia, altered mental status)
  • High persistent fever despite antibiotics
  • Peritoneal signs (guarding, rigidity, rebound)
  • Crepitus over RUQ (emphysematous cholecystitis — gas-forming organisms)
  • Marked leukocytosis (>18 × 10⁹/L)
  • Organ dysfunction (renal, hepatic, cardiovascular)
  • Failure to improve within 24-48 hours of treatment

5. Clinical Examination

Systematic Approach

General Inspection:

  • Unwell appearance (septic)
  • Fever, tachycardia
  • Jaundice (suggests CBD involvement)

Abdominal Examination:

  1. Inspection: Distension (localised or generalised)
  2. Palpation:
    • Murphy's sign: Place hand at costal margin in RUQ; ask patient to inspire; positive if inspiration interrupted by pain
    • RUQ tenderness with guarding
    • Palpable gallbladder (rare)
    • Peritonism (suggests perforation)
  3. Percussion: May be tender; resonance normal unless perforated
  4. Auscultation: Bowel sounds usually present

Murphy's Sign Technique

StepAction
1Position patient supine
2Place examining hand at RUQ costal margin
3Apply gentle pressure over gallbladder area
4Ask patient to take deep breath in
5Positive: Patient catches breath due to pain (inflamed gallbladder descends onto examining hand)
6Compare with LUQ (Murphy's should be negative on left)

6. Investigations

First-Line Investigations

InvestigationFindingsNotes
FBCLeukocytosis (>10 × 10⁹/L)May be very high in gangrenous
CRPElevatedInflammatory marker
LFTsUsually normal; mild bilirubin rise if CBD stoneAST/ALT↑ suggests CBD stone passage
Amylase/LipaseNormal (unless pancreatitis)Exclude gallstone pancreatitis
U&EUsually normalCheck AKI in sepsis
Blood culturesPositive in 20-30%If pyrexial/septic

Imaging

ModalitySensitivityFindings
Ultrasound (US)90-95%Gallstones, wall thickening >3mm, pericholecystic fluid, sonographic Murphy's, sludge
CT Abdomen85-90%Wall thickening, gas in wall (emphysematous), abscess, perforation
HIDA Scan95-98%Non-visualisation of gallbladder = cystic duct obstruction; rarely used acutely
MRCPFor CBD assessmentIf bilirubin elevated, assess for choledocholithiasis

Tokyo Guidelines Diagnostic Criteria (TG18)

A — Local Signs of Inflammation:

  • Murphy's sign
  • RUQ mass/pain/tenderness

B — Systemic Signs of Inflammation:

  • Fever (>38°C)
  • Elevated CRP
  • Elevated WCC

C — Imaging Findings:

  • Characteristic US/CT findings

Diagnosis:

  • Suspected: A + B
  • Definite: A + B + C

7. Management

Management Algorithm

                 ACUTE CHOLECYSTITIS
                        ↓
┌──────────────────────────────────────────────────────────────┐
│                  INITIAL RESUSCITATION                       │
├──────────────────────────────────────────────────────────────┤
│  ➤ NBM                                                       │
│  ➤ IV fluids (crystalloid)                                   │
│  ➤ IV analgesia (paracetamol, opioids PRN)                   │
│  ➤ IV antibiotics (co-amoxiclav or piperacillin-tazobactam)  │
│  ➤ Blood cultures if pyrexial                                │
│  ➤ VTE prophylaxis                                           │
└──────────────────────────────────────────────────────────────┘
                        ↓
┌──────────────────────────────────────────────────────────────┐
│               SEVERITY GRADING (TG18)                        │
├──────────────────────────────────────────────────────────────┤
│  Grade I (Mild): No organ dysfunction; healthy patient       │
│  Grade II (Moderate): Any of: WCC &gt;18, palpable RUQ mass,    │
│                        symptoms &gt;72h, marked local inflam    │
│  Grade III (Severe): Organ dysfunction (CV, neuro, resp,     │
│                       renal, hepatic, haematological)        │
└──────────────────────────────────────────────────────────────┘
                        ↓
┌──────────────────────────────────────────────────────────────┐
│                   SURGICAL MANAGEMENT                        │
├──────────────────────────────────────────────────────────────┤
│  GRADE I (Mild) & GRADE II (Moderate):                       │
│  ➤ Early laparoscopic cholecystectomy (within 72 hours)      │
│  ➤ Same admission surgery preferred                          │
│                                                               │
│  GRADE III (Severe):                                          │
│  ➤ Stabilise and resuscitate in ICU                          │
│  ➤ If unfit for surgery:                                     │
│      • Percutaneous cholecystostomy (PC)                     │
│      • Interval cholecystectomy once fit (~6 weeks)          │
│  ➤ If fit and responding:                                    │
│      • May attempt early cholecystectomy                     │
├──────────────────────────────────────────────────────────────┤
│  SURGICAL OPTIONS:                                            │
│  ➤ Laparoscopic cholecystectomy (first-line)                 │
│  ➤ Open cholecystectomy (if laparoscopic not feasible)       │
│  ➤ Subtotal cholecystectomy (severely inflamed/difficult)    │
└──────────────────────────────────────────────────────────────┘

Antibiotic Regimens

RegimenDoseNotes
Co-amoxiclav1.2g TDS IVFirst-line; covers common biliary organisms
Piperacillin-tazobactam4.5g TDS IVIf more severe or healthcare-associated
Ciprofloxacin + Metronidazole400mg BD + 500mg TDSBeta-lactam allergy
Duration24-48h post-surgery if uncomplicatedLonger if complicated (gangrene, perforation)

Timing of Surgery (Evidence-Based)

TimingOutcome
Early (<72 hours)Preferred; lower morbidity, shorter LOS, fewer complications
Same index admissionBest outcomes; prevents recurrent attacks while waiting
Delayed (>7 days, interval)Higher conversion rates; indicated only if unfit for early surgery

8. Complications

Surgical Complications

ComplicationIncidenceManagement
Bile duct injury0.3-0.6%Recognition and repair; may need ERCP/stent
Bile leak0.5-1%ERCP + stent; drain if collection
Conversion to open5-10%Higher in difficult/gangrenous cases
Bleeding1%Haemostasis; transfusion if significant
Wound infection1-2%Antibiotics; drainage

Disease Complications

ComplicationIncidenceFeatures
Gangrenous cholecystitis15-20%Necrosis of gallbladder wall; perforation risk
Perforation3-10%Localised abscess or generalised peritonitis
Empyema5%Pus-filled gallbladder
Cholecystoenteric fistulaRareErosion into duodenum; may cause gallstone ileus
Mirizzi syndromeRareStone in cystic duct compressing CHD → jaundice

9. Prognosis & Outcomes

Mortality

CategoryMortality
Uncomplicated calculous<1%
Gangrenous5-10%
Perforated10-15%
AcalculousUp to 50% (due to underlying critical illness)

Prognostic Factors

Good PrognosisPoor Prognosis
Early presentationDelayed presentation
Uncomplicated diseaseGangrenous/perforated
Early surgeryDelayed/interval surgery
Young, fit patientElderly, multiple comorbidities
CalculousAcalculous (ICU setting)

10. Evidence & Guidelines

Key Guidelines

GuidelineOrganisationYearKey Points
Tokyo Guidelines (TG18)Japanese Society2018Diagnostic criteria, severity grading, management
NICE Gallstone Disease (CG188)NICE2014 (updated 2017)Recommends laparoscopic cholecystectomy
WSES GuidelinesWorld Society Emergency Surgery2020Emergency surgery pathway

Landmark Trials

ACDC Trial (Gutt et al. 2013)

  • RCT: Early (<24h) vs delayed (7-45 days) laparoscopic cholecystectomy
  • Early surgery: Lower morbidity, shorter hospital stay
  • PMID: 23897963

CHOCOLA Trial (de Mestral et al. 2014)

  • Population-based study supporting early cholecystectomy
  • Same-admission surgery reduces total costs and readmissions
  • PMID: 24859201

Evidence Strength

InterventionLevelEvidence
Early laparoscopic cholecystectomy1aRCTs, meta-analyses
Antibiotics for acute cholecystitis2aCohort/observational
Percutaneous cholecystostomy (high-risk)2bCohort studies

11. Patient/Layperson Explanation

What is Acute Cholecystitis?

Acute cholecystitis is inflammation of the gallbladder — a small organ under your liver that stores bile. It usually happens when a gallstone blocks the tube that drains bile from the gallbladder.

What are the symptoms?

  • Severe pain in the upper right side of your tummy (often after eating fatty food)
  • The pain may spread to your right shoulder or back
  • Fever
  • Feeling sick and vomiting

How is it treated?

Treatment involves:

  1. Hospital admission: You'll need fluids through a drip and antibiotics
  2. Surgery: Keyhole surgery (laparoscopic cholecystectomy) to remove your gallbladder — usually done within 1-3 days
  3. If you're very unwell: A drain may be placed temporarily, with surgery later

Do I need my gallbladder?

The gallbladder stores bile, but you can live perfectly well without it. After removal, bile flows directly from the liver into the intestine.

Recovery

Most people go home 1-2 days after keyhole surgery and fully recover within 1-2 weeks.


12. References

Guidelines

  1. Okamoto K, Suzuki K, Takada T, et al. Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25(1):55-72. PMID: 29090866

  2. NICE. Gallstone disease: diagnosis and management (CG188). 2014 (updated 2017). nice.org.uk

Key Trials

  1. Gutt CN, Encke J, Köninger J, et al. Acute cholecystitis: early versus delayed cholecystectomy. Ann Surg. 2013;258(3):385-393. PMID: 23897963

  2. de Mestral C, Rotstein OD, Laupacis A, et al. Comparative operative outcomes of early and delayed cholecystectomy for acute cholecystitis. Ann Surg. 2014;259(1):10-15. PMID: 24859201


13. Examination Focus

High-Yield Exam Topics

TopicKey Points
Murphy's signInspiratory arrest on RUQ palpation; 65% sens, 87% spec
US findingsStones, wall >3mm, pericholecystic fluid, sonographic Murphy's
Tokyo criteriaLocal + Systemic + Imaging = Definite diagnosis
Treatment timingEarly cholecystectomy (<72h) is superior
Acalculous cholecystitisICU patients; high mortality; high suspicion needed
CholecystostomyBridge to surgery in unfit patients

Sample Viva Questions

Q1: A 55-year-old presents with RUQ pain, fever, and positive Murphy's sign. How do you manage?

Model Answer: This presentation is consistent with acute cholecystitis. Initial management: NBM, IV fluids, IV antibiotics (co-amoxiclav), analgesia. I would request bloods (FBC, LFTs, amylase, CRP) and urgent abdominal ultrasound. If US confirms cholecystitis (gallstones + wall thickening + pericholecystic fluid), I would grade severity using Tokyo criteria and refer for early laparoscopic cholecystectomy — ideally within 72 hours if patient is stable. If severely unwell or unfit for surgery, I would discuss percutaneous cholecystostomy as a bridging option.

Q2: What is the evidence for early vs delayed cholecystectomy?

Model Answer: Multiple RCTs (ACDC, CHOCOLA) and meta-analyses show early laparoscopic cholecystectomy (within 72 hours) is superior to delayed surgery (>7 days). Benefits include shorter total hospital stay, lower morbidity, fewer readmissions (while waiting for interval surgery), and no increased complication rate despite operating on an inflamed gallbladder.

Q3: What is Murphy's sign and how do you elicit it?

Model Answer: Murphy's sign is inspiratory arrest caused by contact between the inflamed gallbladder and the examiner's hand. Technique: With the patient supine, place your hand at the RUQ (subcostal), apply gentle pressure, and ask the patient to take a deep breath in. Positive if pain causes the patient to suddenly stop inspiring. Compare with the left side (should be negative). It has ~65% sensitivity and ~87% specificity for acute cholecystitis.

Common Exam Errors

ErrorCorrect Approach
Recommending delayed surgeryEarly cholecystectomy (<72h) is evidence-based and superior
Forgetting to compare with left sideMurphy's sign should be positive on right, negative on left
Missing acalculous cholecystitisConsider in ICU patients with unexplained sepsis
Not checking LFTsRaised bilirubin/ALP suggests CBD stone (consider MRCP/ERCP)

Last Reviewed: 2025-12-24 | MedVellum Editorial Team


Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists.

Last updated: 2025-12-24

At a Glance

EvidenceHigh
Last Updated2025-12-24
Emergency Protocol

Red Flags

  • Gangrenous cholecystitis
  • Perforation with biliary peritonitis
  • Sepsis/septic shock
  • Emphysematous cholecystitis (gas-forming organisms)
  • Mirizzi syndrome (compression of hepatic duct)
  • Gallbladder empyema

Clinical Pearls

  • **"Early Surgery Saves Lives"**: Landmark trials (ACDC, CHOCOLA) show early cholecystectomy (&lt;72h) is superior to delayed surgery. Don't wait — operate when fit, preferably on index admission.
  • **"The Tokyo Criteria Systematise Diagnosis"**: TG18 requires local signs (Murphy's, RUQ mass) + systemic signs (fever, raised WCC/CRP) + imaging evidence (US findings) for definite diagnosis.
  • **Red Flags — Severe/Complicated Cholecystitis:**
  • - Sepsis or septic shock (hypotension, tachycardia, altered mental status)
  • - High persistent fever despite antibiotics

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines